Tirzepatide Powers Weight Loss in Two More Pivotal Trials ...Middle East

News by : (Medscape) -
Top-line results from another two tirzepatide (Mounjaro) weight-loss pivotal trials in adults without diabetes padded the agent's sizeable evidence base and presaged likely FDA approval later in 2023. Medscape Medical News

Hence then, the article about tirzepatide powers weight loss in two more pivotal trials was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tirzepatide Powers Weight Loss in Two More Pivotal Trials )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار